Skip to main content

POLICY AND PRACTICE REVIEWS article

Front. Bioeng. Biotechnol.
Sec. Biosafety and Biosecurity
Volume 12 - 2024 | doi: 10.3389/fbioe.2024.1474120
This article is part of the Research Topic Insights In Biosafety & Biosecurity 2024/2025: Novel Developments, Current Challenges, and Future Perspectives View all articles

Establishing a National Biosafety and Biosecurity Agency for the United States

Provisionally accepted
  • 1 Research and Innovation, University of Nevada, Reno, Reno, United States
  • 2 School for the Future of Innovation in Society, Arizona State University, Tempe, Arizona, United States
  • 3 Tutela Strategies, LLC, Reno, Nevada, United States
  • 4 Office of the Vice President for Research, Colorado State University, Fort Collins, CO, USA, Fort Collins, United States
  • 5 Schar School of Policy and Government, George Mason University, Arlington, Virginia, United States

The final, formatted version of the article will be published soon.

    The rapid advancement of biological research and biotechnology requires a novel and robust regulatory agency to ensure uniform biosafety and biosecurity governance in the United States. The current fragmented regulatory landscape needs to be refocused to address the complexities of modern biological research, including risks associated with accidental, inadvertent, and deliberate biological incidents. An independent government agency, which we call the National Biosafety and Biosecurity Agency (NBBA), that is devoted to biosafety and biosecurity could effectively address these challenges. The NBBA would consolidate various regulatory functions, streamline processes, and enhance oversight. This oversight would encompass life sciences research in the United States, regardless of the source of funding or level of classification. The agency could also contribute to the bioeconomy by streamlining requirements to safeguard public health and the environment while fostering scientific and commercial progress. The proposed agency would govern highrisk biological pathogens, manage the Federal Select Agent Program, enforce policies related to dual use research of concern, pathogens with enhanced pandemic potential, and nucleic acid synthesis screening, administer regulations on the use and care of laboratory animals, as well as regulate other relevant biosafety and biosecurity activities. The goal would be to provide one-stop shopping for the biomedical research and biotechnology sectors subject to oversight by the Federal government. To ensure leadership in global biosafety and biosecurity, the agency's mission would include international collaboration, applied research, education, workforce development, and coordination with national security initiatives. Creating an agency like the NBBA will be politically challenging but presenting a comprehensive vision and engaging stakeholders early and frequently, and being transparent in the process, will be essential for garnering support. Creating a unified biosafety and biosecurity governance system in the United States will ensure the safe and secure advancement of biological research while sustaining innovation and maintaining international competitiveness.

    Keywords: biosafety, biosecurity, legislation, Biotechnology regulation, Incident Response, Unified Biosafety Agency, international collaboration

    Received: 01 Aug 2024; Accepted: 08 Oct 2024.

    Copyright: © 2024 Gillum, Moritz and Koblentz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Gregory D. Koblentz, Schar School of Policy and Government, George Mason University, Arlington, 22201, Virginia, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.